spacer
home > pmps > autumn 2008 > mes gets you to market quicker
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES Gets You to Market Quicker

Probably the biggest single driver for any manufacturer in the pharmaceutical industry has to be the time it takes to get a potential product through the research and development phases and out to market.

With R&D costs to bring a new drug to release approximated at $1 million a day, only when a product is in daily use does the huge investment undertaken by drug companies seeking the next blockbuster product begin to pay back.

There are plenty of examples, across many industries, of companies being late to market with a product, only to find further down the line that competitors’ products have subsequently appeared, with a resulting substantial hit in potential operating profits. Once a company is in the process of research...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mark Perry has held a number of senior positions, including Sales Director for ABB Process Instrumentation & Micro Control Systems and General Manager for Rockwell Automation EMEA Asset Management. He joined Siemens in 2003 as General Sales Manager for the Process Instrumentation Group before moving into the automation and drives process sector, heading up teams focusing on the chemical/pharmaceutical, food and beverage and oil and gas sectors. In 2007, Mark took up the position as Business Manager for the Siemens UK MES group, with responsibility for, among others, the pharmaceutical industry.
spacer
Mark Perry
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement